ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,116.17
0.00%
US Tech 100
17,288.80
-0.12%
Dow Jones
38,386.09
0.00%
Brent Oil
87.635
0.40%
Bitcoin
61,143.29
-4.22%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Treace Medical Concepts Inc (TMCI) Quote

Treace Medical Concepts Inc

Treace Medical Concepts Inc (TMCI)

NASDAQ
10.65
0.25
(2.40%)
Closed April 29 4:00PM
Delayed by 15 minutes
10.65
0.00
( 0.00% )
Pre Market: 7:00AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
10.65
Bid
9.35
Ask
10.94
Volume
-
0.00 Day's Range 0.00
5.27 52 Week Range 27.70
Market Cap
657.692M
Previous Close
10.65
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
396,060
Shares Outstanding
61,755,146
Dividend Yield
-
PE Ratio
-13.28
Earnings Per Share (EPS)
-0.8
Revenue
187.12M
Net Profit
-49.53M

About Treace Medical Concepts Inc

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of ... Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.treace.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Treace Medical Concepts Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker TMCI. The last closing price for Treace Medical Concepts was $10.65. Over the last year, Treace Medical Concepts shares have traded in a share price range of $ 5.27 to $ 27.70.

Treace Medical Concepts currently has 61,755,146 shares outstanding. The market capitalization of Treace Medical Concepts is $657.69 million. Treace Medical Concepts has a price to earnings ratio (PE ratio) of -13.28.

TMCI Latest News

More News

Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour

DALLAS and PONTE VEDRA, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- The Professional Pickleball Association (PPA) Tour and Treace Medical Concepts, Inc. (NasdaqGS: TMCI), a medical technology...

April 24 2024
GlobeNewswire Inc.

Treace to Present at Bank of America Health Care Conference

PONTE VEDRA, Fla., April 17, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...

April 17 2024
GlobeNewswire Inc.

Treace Announces First Annual National Bunion Day

PONTE VEDRA, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...

April 16 2024
GlobeNewswire Inc.

Treace to Report First Quarter 2024 Financial Results

PONTE VEDRA, Fla., April 09, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...

April 09 2024
GlobeNewswire Inc.

Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone

Treace Further Expands Focus on Bunion Deformity Education by Sponsoring First-Ever National Bunion Day in the U.S. on April 16, 2024 Launches New “Future You” Patient Education and Brand...

March 25 2024
GlobeNewswire Inc.

Form 8-K - Current report

February 27 2024
Edgar (US Regulatory)

Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance

PONTE VEDRA, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...

February 27 2024
GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

February 09 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.46-4.140414041411.1111.3910.2333767210.54890058CS
4-1.47-12.128712871312.1212.7410.2331062211.49099172CS
12-3.08-22.43262927913.7315.9810.2339606013.02951835CS
261.0210.59190031159.6315.985.2769609010.59990209CS
52-14.17-57.091055600324.8227.75.2760351313.53038185CS
156-18.66-63.664278403329.3137.175.2738308117.93681917CS
260-13.85-56.530612244924.537.175.2738879718.13775024CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CYCCCyclacel Pharmaceuticals Inc
$ 2.1099
(55.14%)
5.41M
BRTXBioRestorative Therapies Inc
$ 1.67
(34.68%)
4.95M
MRINMarin Software Incorporated
$ 3.43
(31.42%)
2.94M
EGOXNext e GO NV
$ 0.036
(30.43%)
39.36M
WRNTWarrantee Inc
$ 0.3507
(29.89%)
11.41k
LICNLichen China Limited
$ 1.66
(-18.23%)
244.25k
GNTAGenenta Science SPA
$ 2.49
(-15.59%)
5
CSLRComplete Solaria Inc
$ 0.6216
(-14.87%)
264.39k
MNYMoneyHero Ltd
$ 1.81
(-12.98%)
1.02k
CALCCalciMedica Inc
$ 4.85
(-11.74%)
6
EGOXNext e GO NV
$ 0.036
(30.43%)
39.36M
GWAVGreenwave Technology Solutions Inc
$ 0.0727
(11.85%)
36.28M
JAGXJaguar Health Inc
$ 0.2181
(4.86%)
8.62M
CYCCCyclacel Pharmaceuticals Inc
$ 2.1098
(55.13%)
5.42M
BRTXBioRestorative Therapies Inc
$ 1.67
(34.68%)
4.95M

Discussion

View Full Feed
BlazingStocks BlazingStocks 4 minutes ago
$WRIT News April 29, 2024

WRIT Media Group, Inc. Announces Digital Marketing and Merchandising Agreement with Patriots Fest Music Festival Set for May 18th 2024, at the Piazza Complex in Aurora Illinois
https://www.otcmarkets.com/stock/WRIT/news/WRIT-Media-Group-Inc-Announces-D
WRIT
goingUPagain goingUPagain 4 minutes ago
When would IDE approval happen.. ? Timeline…Thanks !
RDGL
jedijazz jedijazz 4 minutes ago
$NRXP $3.63 +2.25% "The new national strategy focuses on a "whole of society" approach, which is unique-and critical -because no single entity alone can reduce suicide rates. But together, we have a real opportunity for impact." - NAM Chief Advocacy Officer https://t.co/FKUyFTYbUj https://twitter.co
NRXP
PennyMillions852 PennyMillions852 4 minutes ago
I think .002 break possible on this next run if Acquisition is Big! $CBIA, .0017 last time, so with AI, possible debt pay off and Acquisition this time, even bigger run!
CBIA
MightyX MightyX 4 minutes ago
“Targeted” isn’t proper word. It’s the marketplace and how trades are conducted first that needs to be addressed.
SOFI
wickerman wickerman 4 minutes ago
$AUUD $5+ open? The FTD # must be massive.

https://investors.auddiainc.com/news/auddia-announces-breakthrough-in-ai-and-natural-language-processing-technology-for-podcasts
AUUD
SilkRoad SilkRoad 5 minutes ago
It certainly appears that even bigger news is in the works. Yesterday was the reveal of another solid support. Kim and his team’s labors are paying off. I cannot wait to see what comes next.
KBLB
eastunder eastunder 5 minutes ago
PayPal Earnings Pop 27% Under New Reporting Method. PayPal Stock Is Set To Break Out.
FacebookTwitterLinkedInShare Licensing
REINHARDT KRAUSE08:05 AM ET 04/30/2024

PayPal Holdings (PYPL) early Tuesday reported first-quarter earnings that rose 27% from a year earlier unde
AAPL PYPL
monocle monocle 5 minutes ago
Pretty good news for IBC

https://mailchi.mp/ibcadvancedalloys/ibc-advanced-alloys-announces-entering-into-sale-leaseback-agreements?e=cd1c49f588

Besides Mark's loan, does the company now have any other debt?
IAALF
iamthe walrus iamthe walrus 5 minutes ago
Aristice Capital looks to be the primary seller now .. According to the OTC Market site as of March 31 2024 they had 96 million warrants exercisable when CRTG OS count was 301 million . The count as of April 26th 2024 at the OTC Market site was now 315 million. That has to be Armistice receiving mor
CRTG
Louied91 Louied91 6 minutes ago
$HALB Halberd's Patented LDN+ Drug Has Begun Pre-Pilot Trials With Military Veterans

https://www.accesswire.com/857948/halberds-patented-ldn-drug-has-begun-pre-pilot-trials-with-military-veterans

LDN+ Drug Designed to Combat PTSD and Suicidal Ideation

JAC
HALB
Lokotony Lokotony 6 minutes ago
How about we just talk about the viability of this stock.....go or bad. I can see pessimism, but if you are bashing, go away.
BITF
researcher59 researcher59 6 minutes ago
RITM (11.22) posts strong Q1 results - dividend yield is 8.9% for this mortgage REIT -

PR -

GAAP net income of $261.6 million, or $0.54 per diluted common share
Earnings available for distribution of $233.2 million, or $0.48 per diluted common share
Commo
RITM
ChannelTrader ChannelTrader 6 minutes ago
Ronald Reagan is responsible for authorizing big pharma immunity nearly 40 years ago in the mid 1980's

42 U.S. Code § 300aa–22 - Standards of responsibility

https://www.law.cornell.edu/uscode/text/42/300aa-22

What is the Reagan vaccine Immunity Act?
JohnTrades JohnTrades 6 minutes ago
9M PREMARKET VOL AND RISING, HOLD FOR GOLD GENTS
JAGX
PennyHoper PennyHoper 6 minutes ago
Watch for the "Now Open" front-page pop-up.

I hope they start putting links to these restaurants somewhere easy to spot/find, rather than relying on accidental discovery.
learningcurve2020 learningcurve2020 6 minutes ago
Direct has been stuck in neutral for a decade while L has taken at least five years longer than planned to maybe squeak out a positive sign. Congrats!!!
NWBO
hotdawg hotdawg 7 minutes ago
Congratulations on picking up the .0037's and every one elst that was on the bid when someone dumped all of those shares yesterday.
We as a group are soaking up every share we can.
BLEG
KCCO7913 KCCO7913 7 minutes ago
The only reason why they would never be accepted is if they fail their reliability testing. Data we’ve seen so far shows excellent reliability.

Compared to TFLN modulators, EOP is smaller and more efficient. They also have a higher bandwidth. EOP is silicon foundry compatible while T
LWLG
Lokotony Lokotony 7 minutes ago
Not to argue, but I've followed SOFI for awhile. Def targeted! Not little offices out of the garage. Major bank.....even have their own stadium.
SOFI
sundoctor sundoctor 8 minutes ago
Great News:
Halberd's Patented LDN+ Drug Has Begun Pre-Pilot Trials With Military Veterans
LDN+ Drug Designed to Combat PTSD and Suicidal Ideation
HALB
scubastevemd scubastevemd 8 minutes ago
Talk about a rigged election. Do we live in Russia or China? And the BOD is going along with this? Shame on all of them!
PLUG
jackson73 jackson73 8 minutes ago
BRTX ww on news
BRTX
Kjv Kjv 8 minutes ago
Can’t you guys see this pattern repeatedly? Since November? Has there ever been a tweet without dilution?

Wait a few months for “amnesia “ then come back and suck newbies in. Lie about acquisition, government contracts, NASDAQ team up…..and you guys keep falling for this crook?
CBIA DTC

Your Recent History

NASDAQ
TMCI
Treace Medical Concepts
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved